C12N 2710/14023
Virus like particles [vlp]
Official title: Virus like particles [VLP]
C12N2710/14023 (Virus like particles [vlp]) appears on 5 US grants and 8 published applications in this corpus.
Search patents in C12N- Granted patents
- 5
- Published applications
- 8
- Assignees
- 4
- Inventors
- 8
- Latest grant
- 1 Oct 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2007 | 0 | 1 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 1 |
| 2012 | 0 | 0 |
| 2013 | 1 | 1 |
| 2014 | 0 | 0 |
| 2015 | 0 | 1 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 1 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 1 |
| 2021 | 0 | 0 |
| 2022 | 1 | 1 |
| 2023 | 1 | 0 |
| 2024 | 1 | 1 |
| 2025 | 0 | 1 |
By publication year.
Recent patents
- Universal influenza vaccine1 Oct 2024US 12,102,674 B2Cambridge Technologies, Inc.
- Universal influenza vaccine3 Oct 2023US 11,771,756 B2Cambridge Technologies, Inc.
- Universal influenza vaccine7 Jun 2022US 11,351,241 B2Cambridge Technologies, Inc.
- Baculovirus system for expressing proteins forming virus-like particles30 Jan 2018US 9,879,280 B2Alternative Gene Expression S.L.
- Lipoparticles comprising ion channels, methods of making and using the same19 Feb 2013US 8,377,691 B2Integral Molecular, Inc.
- Cytolytic t cell immunotherapy for highly pathogenic coronaviruses4 Sep 2025US 2025/0276056 A1
- Universal influenza vaccine21 Mar 2024US 2024/0091336 A1Cambridge Technologies, Inc.
- Universal influenza vaccine22 Sep 2022US 2022/0296698 A1Cambridge Technologies, Inc.
- Universal influenza vaccine18 Jun 2020US 2020/0188505 A1Cambridge Technologies, Inc.
- Baculovirus system for expressing proteins forming virus-like particles29 Oct 2015US 2015/0307899 A1Alternative Gene Expression S.L.
Most cited
By later US patents
- Lipoparticles comprising ion channels, methods of making and using the same5US 8,377,691 B2Integral Molecular, Inc. · 2013
- Universal influenza vaccine2US 11,351,241 B2Cambridge Technologies, Inc. · 2022
- Universal influenza vaccine1US 11,771,756 B2Cambridge Technologies, Inc. · 2023
- Baculovirus system for expressing proteins forming virus-like particles1US 9,879,280 B2Alternative Gene Expression S.L. · 2018